Donate For Public and Patients Store Search

Go to AAD Home
Welcome!
Advertisement
Advertisement

2022 Annual Meeting: Industry Product Sessions


See what's new with industry during these educational and product-oriented sessions. These unique sessions provide exhibiting companies the opportunity to:

  • Present new research findings on products

  • Detail products

  • Conduct demonstrations

  • Highlight new products

These sessions are solely promotional and are not eligible for CME credit.

Session schedule

  • Theater 1
  • Theater 2
  • Friday, March 25, 2022
    Location: Exhibit Hall, Booth 4471

    Date
    Time       
    Location
    Title
    Description
    Hosted by

    Friday, March 25

    10:30 a.m. - 11:15 a.m
    Booth 4471

    Immune-Inflammatory Dermatological Diseases: Mechanisms and Manifestations

    An exploration of the underlying pathophysiological features and pathways involved in immune-mediated dermatological diseases, and how these changes manifest in a clinical setting.

    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Pfizer

    Friday, March 25

    12:00 p.m. - 12:45 p.m
    Booth 4471

    Advancing Sensitive Skin: Diagnosis, Morphological Traits and Epidemiology

    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Galderma

    

    Friday, March 25
    1:30 p.m. - 2:15 p.m.

    Booth 4471

    Pathophysiology of Inflammation in Atopic Dermatitis
    Come learn more about the pathophysiology of inflammation in atopic dermatitis. Also, learn about a treatment that may help your patients with uncontrolled moderate-to-severe atopic dermatitis.
    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Sanofi-Regeneron

    Friday, March 25
    3:00 p.m. - 4:15 p.m.
    Booth 4471
    Managing Plaque Psoriasis Across All Severities: An Oral Therapy with Data in Difficult-to-Treat Areas
    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Amgen

    


    Saturday, March 26, 2022
    Location: Exhibit Hall, Booth 4471

    Date    
    Time       
    Location
    Title
    Description
    Hosted by

    Saturday, March 26

    10:30 a.m. - 11:15 a.m
    Booth 4471

    Join Pfizer | Learn About A Now Approved Oral Rx Treatment for Moderate-to-Severe Atopic Dermatitis

    Introducing CIBINQO™ (abrocitinib) for adults with refractory, moderate-to-severe atopic dermatitis. Join Pfizer for a non-CME, educational program discussing the efficacy and safety of this treatment. Full PI available at CIBINQOPI.com.

    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Pfizer

    


    Saturday, March 26

    12:00 p.m. - 12:45 p.m
    Booth 4471

    A New Treatment for Adults with Uncontrolled Moderate-to-Severe Atopic Dermatitis

    During this presentation, we will review atopic dermatitis pathophysiology and discuss a new treatment option for moderate-to-severe atopic dermatitis in adult patients whose disease is not adequately controlled.
    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Leo Pharma

    

    Saturday, March 26
    1:30 p.m. - 2:15 p.m.

    Booth 4471

    Periocular Locally Advanced BCC – A Case Study Discussion

    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>SUN Pharma


    Sunday, March 27, 2022
    Location: Exhibit Hall, Booth 4471

    Date    
    Time       
    Location
    Title
    Description
    Hosted by

    Sunday, March 27

    10:30 a.m. - 11:15 a.m
    Booth 4471

    Alopecia Areata: What you need to know

    Drs. Brett King, Maryanne Senna, and Crystal Aguh present this Pfizer-sponsored program, reviewing: Patient burden of AA, Severity assessment tools, AA pathophysiology.

    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Pfizer

    

    Sunday, March 27

    12:00 p.m. - 12:45 p.m
    Booth 4471

    A Presentation by Sanofi Genzyme and Regeneron


    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Sanofi-Regeneron

    Sunday, March 27
    1:30 p.m. - 2:15 p.m.

    Booth 4471

    Multidisciplinary Management of Advanced Non-Melanoma Skin Cancer

    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Sanofi-Regeneron

    Friday, March 25, 2022
    Location: Exhibit Hall, Booth 3571

    Date    
    Time       
    Location
    Title
    Description
    Hosted by

    Friday, March 25

    10:30 a.m. - 11:15 a.m
    Booth 3571

    Groundbreaking acne treatment: TWYNEO Cream dermatology’s only combination .1% tretinoin and 3% BPO for moderate to severe acne vulgaris

    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Galderma

    Friday, March 25

    12:00 p.m. - 12:45 p.m
    Booth 3571

    Taltz: See the Difference - An Overview of Long-Term Efficacy and Safety

    Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. To learn more, visit us at www.lilly.com.

    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Lilly

    Friday, March 25
    1:30 p.m. - 2:15 p.m.

    Booth 3571

    New Developments in Patients with Epidermolysis Bullosa

    This presentation will provide information on the management of patients with EB, including the clinical and safety information on treatment. Following the presentation, there will be an interactive discussion session.

    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Amryt
    Friday, March 25
    3:00 p.m. - 3:45 p.m.
    Booth 3571
    TYK2 as a Central Link Between IL-23 and IL-17, and the Significance of Kinase Structures
    This product theater highlights the role of TYK2 in the IL-23/IL-17 axis, and structural and functional differences from JAK1/2/3. Next, key structural features of kinases as a class are investigated.
    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>BMS


    Saturday, March 26, 2022
    Location: Exhibit Hall, Booth 3571

    Date    
    Time       
    Location
    Title
    Description
    Hosted by

    Saturday, March 26

    10:30 a.m. - 11:15 a.m
    Booth 3571

    Pediatric Atopic Dermatitis: Current Developments


    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Galderma

    Saturday, March 26

    12:00 p.m. - 12:45 p.m
    Booth 3571

    The challenge of prurigo nodularis: A distinct, chronic skin disease with substantial burden and unmet needs

    Join us as we discuss the distinctive clinical presentation, epidemiology, and patient burden of prurigo nodularis and current consensus statements for the management of prurigo nodularis, as well as unmet clinical needs.

    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Sanofi-Regeneron

    Saturday, March 26
    1:30 p.m. - 2:15 p.m.

    Booth 3571

    Atopic Dermatitis: The Burden of Disease and a Novel Topical Pathway

    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Incyte


    Sunday, March 27, 2022
    Location: Exhibit Hall, Booth 3571

    Date    
    Time       
    Location
    Title
    Description
    Hosted by

    Sunday, March 27

    10:30 a.m. - 11:15 a.m
    Booth 3571

    Biologics Expert Session (PT)


    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>SUN Pharma

    Sunday, March 27

    12:00 p.m. - 12:45 p.m
    Booth 3571

    A Neuroimmune Perspective on Itch and Skin Inflammation in Atopic Dermatitis and Prurigo Nodularis – Introducing IL-31


    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Galderma
    Sunday, March 27
    1:30 p.m. - 2:15 p.m.

    Booth 3571

    Learn about the multidisciplinary management of advanced CSCC and locally advanced BCC

    This presentation will discuss the importance of multidisciplinary management of locally advanced BCC and advanced CSCC, clinical trial results and patient case studies for an FDA-approved systemic therapy.

    
    Member>Meetings-Education>AM2022>Exhibit hall>Industry Product Sessions>Sanofi-Regeneron

    Advertisement